SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-252785
Filing Date
2021-08-20
Accepted
2021-08-20 16:27:55
Documents
2
Group Members
AJAY ROYANMITHRIL II GP LPMITHRIL II UGP LLCPETER THIEL

Document Format Files

Seq Description Document Type Size
1 SC 13D d204598dsc13d.htm SC 13D 112854
2 EX-99.1 d204598dex991.htm EX-99.1 6766
  Complete submission text file 0001193125-21-252785.txt   121269
Mailing Address ONE LETTERMAN DRIVE, BLDG. A, SUITE 4900 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE, BLDG. A, SUITE 4900 SAN FRANCISCO CA 94129 (415) 659-8940
MITHRIL II LP (Filed by) CIK: 0001669609 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 (781) 530-3600
Adagio Therapeutics, Inc. (Subject) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92804 | Film No.: 211194154
SIC: 2836 Biological Products, (No Diagnostic Substances)